Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500719PMID: 29999778
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 14596-37-3
Drug Levels and Effects
Summary of Use during Lactation
Information in this record refers to the use of phosphorus P 32 as a therapeutic agent. No information is available on the use of phosphorus P 32 during breastfeeding. Use of phosphate P 32 as a skin patch to treat skin cancers poses no risk to breastfed infants after removal of the patch from the mother's skin
Drug Levels
Phosphorus P 32 decays by beta emission with an energy of 1.709 MeV and a half-life of 14.3 days.[1]
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Mountford PJ, Wells CP, Hall FM, et al. Potential radiation dose to a breast-fed infant following administration of sodium 32P-phosphate to the mother. Nucl Med Commun. 1984;5:473–6. [PubMed: 6531156]
Substance Identification
Substance Name
Phosphorus P 32
CAS Registry Number
14596-37-3
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Breastfeeding for procedural pain in infants beyond the neonatal period.[Cochrane Database Syst Rev. 2016]Breastfeeding for procedural pain in infants beyond the neonatal period.Harrison D, Reszel J, Bueno M, Sampson M, Shah VS, Taddio A, Larocque C, Turner L. Cochrane Database Syst Rev. 2016 Oct 28; 10(10):CD011248. Epub 2016 Oct 28.
- Breastfeeding or breast milk for procedural pain in neonates.[Cochrane Database Syst Rev. 2023]Breastfeeding or breast milk for procedural pain in neonates.Shah PS, Torgalkar R, Shah VS. Cochrane Database Syst Rev. 2023 Aug 29; 8(8):CD004950. Epub 2023 Aug 29.
- Early discharge with home support of gavage feeding for stable preterm infants who have not established full oral feeds.[Cochrane Database Syst Rev. 2025]Early discharge with home support of gavage feeding for stable preterm infants who have not established full oral feeds.Rumbold AR, Keir A, Collins CT, Cooper C, Shepherd ES. Cochrane Database Syst Rev. 2025 May 13; 5(5):CD003743. Epub 2025 May 13.
- Review Cannabis.[Drugs and Lactation Database (...]Review Cannabis.. Drugs and Lactation Database (LactMed®). 2006
- Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.[Cochrane Database Syst Rev. 2010]Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Sturt AS, Dokubo EK, Sint TT. Cochrane Database Syst Rev. 2010 Mar 17; 2010(3):CD008440. Epub 2010 Mar 17.
- Phosphorus P 32 - Drugs and Lactation Database (LactMed®)Phosphorus P 32 - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...